# Plasma Cell Dyscrasias
 
Plasma Cell Dyscrasias – Jennifer Marvin-Peek

Background

-   A heterogenous group of benign, premalignant, and malignant
    conditions characterized by clonal proliferation of plasma cells
-   Results in production of monoclonal immunoglobulins or polypeptides
    (i.e. monoclonal proteins, or M-protein) in serum and/or urine
-   Includes monoclonal gammopathy of undetermined significance (MGUS),
    smoldering myeloma (SMM), multiple myeloma (MM), Waldenstrom’s
    macroglobulinemia (WM), extra-medullary plasmacytoma, AL
    amyloidosis, POEMS syndrome, Castleman’s disease
-   Complications: Increased infectious risk, renal failure,
    hyperviscosity syndrome, malignant hypercalcemia, pain crisis from
    bony disease

| 0                                                                                                                                                                            | 1                                                                                                                                                                                                                                     |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Symptoms                                                                                                                                                                     | Signs                                                                                                                                                                                                                                 |
| Fatigue, weakness, weight loss Bone pain Paresthesias, neuropathy, radiculopathy Visual disturbances (if hyperviscosity present) Lymphadenopathy (uncommon) Fever (uncommon) | Anemia (Hgb \<10) Renal insufficiency (Cr \> 2) Hypercalcemia (Ca \> 11.5) Elevated protein gap (Total protein - Alb \> 4) Osteolytic bone lesions (typically central) Unexplained heavy proteinuria Rouleux formation on blood smear |

Evaluation

-   CBC
    w/ diff, BMP (for Ca, Cr)
-   SPEP with immunofixation, UPEP (24 hour urine) with immunofixation,
    urinalysis, serum free light chains (FLC)
-   Quantitative immunoglobulins (IgA, IgM, IgG, IgD, IgE)
-   If  Hgb \<10, Cr >2, Ca >11.5, M-protein >1.5, non-IgG M-spike,
    abnormal FLC ratio:
    -   Bone marrow biopsy + cytogenetics, peripheral blood smear review
    -   LDH, albumin, CRP,
        β
        2-microglobulin, serum viscosity
    -   Skeletal survey

| 0                                                                                                                                                                                                   | 1                                                                                                                                                                                                                                                 | 2                                                                                                                                                                                                                                   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Additional Tips for Lab Interpretation                                                                                                                                                              | Additional Tips for Lab Interpretation                                                                                                                                                                                                            | Additional Tips for Lab Interpretation                                                                                                                                                                                              |
| SPEP/UPEP                                                                                                                                                                                           | Free light chains (FLC)                                                                                                                                                                                                                           | Urinalysis                                                                                                                                                                                                                          |
| Immunofixation determines clonality (e.g. mono or polyclonal) Monoclonal spike \>1.5 is indicative of underlying dyscrasia Polyclonal spike suggests infectious, inflammatory, or reactive etiology | Ratio of kappa/lambda \>3 highly suggestive of plasma cell dyscrasia -Ratio 1.65 to 3 can be due to infectious process or renal insufficiency Helpful in pts that only produce bence jones protein (FLC w/o heavy chain) which isn’t seen on SPEP | Detects albumin, not light chains In myeloma cast nephropathy, get negative dipstick since proteinuria is from FLC (i.e. Bence Jones proteinuria) In AL amyloid, dipstick will be positive 2/2 albumin loss from nephrotic syndrome |

| 0                           | 1                                                         | 2                                                                                | 3                                            |
|-----------------------------|-----------------------------------------------------------|----------------------------------------------------------------------------------|----------------------------------------------|
| NaN                         | Monoclonal Gammopathy of Unknown Significance (MGUS)      | Smoldering Multiple Myeloma (SMM)                                                | Multiple Myeloma (MM)                        |
| % Plasma Cells in BM        | \<10%                                                     | 10-60%                                                                           | ≥ 10% (typically \>30%)                      |
| Monoclonal Protein          | IgG, IgA, IgM: 1.5 -3                                     | IgG or IgA \>3                                                                   | IgG or IgA \>3                               |
| Laboratory studies          | Normal Hgb, Ca, Cr                                        | Normal Hgb, Ca, Cr                                                               | ↓Hgb, ↑Ca, ↑Cr                               |
| Symptoms                    | None                                                      | None                                                                             | Lytic bone lesions, fatigue                  |
| Prognosis                   | 1% / year progression to MM                               | 10% / year progression to MM                                                     | R-ISS staging (see below)                    |
| Monitoring and/or Treatment | Monitoring only Yearly: Symptom check SPEP, FLC, CBC, BMP | Monitoring only In 2-3 months, repeat SPEP, FLC, CBC, BMP Yearly skeletal survey | Chemotherapy, plus SCT for eligible patients |

Multiple Myeloma

Evaluation

-   Diagnosis requires:
    -   One of:
        -   Clonal
            bone marrow plasma cells >10%
    -   Biopsy
        proven extramedullary plasmacytoma (tumor of plasma cells) AND
        ≥1 myeloma-defining event:
        -   One or more of the CRAB criteria
        -   Clonal
            bone m
            arrow plasma cells ≥ 60%
        -   Serum
            FLC ratio ≥ 100 or ≤0.01
        -   \>1
            focal
            lesion larger than 5mm on MRI

Management

-   Active disease: induction includes a proteasome inhibitor
    (bortezomib or carfilzomib)
-   Consolidation therapy includes SCT for eligible patients \<65-70
    years old
-   Maintenance therapy is often given indefinitely, typically
    lenalidomide and/or bortezomib
-   VTE prophylaxis if on an immunomodulatory agent with 2 VTE risk
    factors
    -   If only 0-1
        VTE
        risk factors
        
        aspirin
-   Supportive Care: EPO for anemia, analgesia ± radiotherapy for bone
    pain, vaccinations
-   Bisphosphonate (ideally zoledronic acid)
-   (Val)Acyclovir ppx if on bortezomib

Additional Information

-   Prognosis
    -   Revised Multiple Myeloma International Staging System (R-ISS)
        (available on MD Calc)
        -   Serum
            β
            2-microglobulin (indicator of plasma cell turnover)
        -   Serum albumin
        -   Serum LDH
    -   Cytogenetic markers from biopsy

Lymphoplasmacytic Lymphoma

Waldenstrom’s Macroglobulinemia (IgM)

Presentation

-   Hyper-viscosity syndrome
    : blurred vision, dizziness, diplopia, ataxia, vertigo stroke, coma
-   Peripheral neuropathy
-   Retinal changes: dilated veins, hemorrhages, papilledema
-   Cryoglobulinemia: large IgM complexes precipitate out in the cold,
    causing Raynaud's, urticaria, purpura, acral cyanosis, tissue
    necrosis

Evaluation

-   Requires: IgM monoclonal gammopathy on SPEP,  BM biopsy w/≥10%
    plasma cells, and MYD88 mutation detected
-   CBC, coagulation studies, cryoglobulins, IgM,
    β
    2-microglobulin
-   Serum viscosity (If \<4 symptoms are rare, If >6 typically
    symptomatic)

Management

-   Only treated if symptomatic
-   If Hyper-viscosity syndrome treatment in Plasma Exchange
-   Induction: may include bendamustine +/- rituximab if IgM level is
    \<4000 (Rituximab can temporarily
    ↑
    IgM and
    ↑
    risk of hyperviscosity syndrome)
-   Monitor response with: IgM levels, monoclonal IgM on SPEP

Other Plasma Cell Dyscrasias

Light Chain (AL) Amyloidosis

-   Extracellular deposition of misfolded light chains
-   Most commonly kidney & heart
-   Features:
    ​​​​​​​
    -   Nephrotic syndrome
    -   Restrictive CM
    -   Peripheral neuropathy
    -   Hepatomegaly
    -   Macroglossia
    -   Easy bruising/bleeding
    -   Orthostasis

<!-- -->

-   Diagnosis:
    -   Need
        ALL
        4:
        ​​​​​​​
        -   Amyloid related systemic syndrome
        -   Positive congo red staining on any tissue
        -   Evidence that amyloid is light chain related
        -   Evidence of monoclonal plasma cell disorder ​​​​​​​

POEMS Syndrome

-   Unknown, possibly chronic overproduction of pro-inflammatory
    cytokines such as **VEGF**
-   Features:
    P
    olyneuropathy, **O** rganomegaly, **E** ndocrinopathy, **M**
    onoclonal protein (usually
    λ
    light chain), **S** kin changes
-   Diagnosis:
    -   Mandatory Criteria
        ​​​​​​​
        -   Peripheral neuropathy
        -   Monoclonal plasma cell disorder ​​​​​​​
    -   Major Criteria (need 1/3)
        -   Osteosclerotic lesions, VEGF, Castleman disease
    -   ​​​​​​​
        Minor Criteria (need 1/6)
        -   ​​​​​​​
            Organomegaly
        -   Volume overload
        -   Endocrinopathy
        -   Skin changes
        -   Papilledema
        -   Thrombocytosis or polycythemia

Castleman Disease

-   Angiofollicular lymph node hyperplasia
-   Antibodies to HHV-8 implicated in >50% of cases
-   Features
    : **Lymphadenopathy** , Fever, night sweats, fatigue, Fluid
    accumulation
-   Skin findings: violaceous Lymph node biopsy w/characteristic
    hematopathology papules
